Aurinia Pharma US Inc.
Rockville, MD
- UEI
- Y394MPDW6GH4
- CAGE
- 8RTT6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 77 Upper Rock Cir #700, Rockville, MD 20850, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Voclosprin for inmate claybon 59340-509 | Federal Correctional Institution Aliceville (BOP) | $0 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Corcept Therapeutics Incorporated | Redwood City, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Astellas Pharma US, Inc. | Northbrook, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Mylan Pharmaceuticals Inc. | Morgantown, WV | 325412 Pharmaceutical Preparation Manufacturing |
| Acer Therapeutics Inc. | Boston, MA | 456110 Pharmacies and Drug Retailers |
| Servier Pharmaceuticals LLC | Boston, MA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Aurinia Pharma US Inc. is a for-profit corporate entity that provides pharmaceuticals and drugs to U.S. government customers. As a prime contractor, Aurinia has received federal awards to supply immunosuppressant medications used to treat conditions like lupus nephritis.
Past federal contract awards to Aurinia include a November 2022 delivery order from the Department of Justice's Bureau of Prisons to provide the drug voclosporin to an inmate at the Federal Correctional Institution in Aliceville, Alabama. This firm fixed price order leveraged Aurinia's existing GSA Schedule contract for Pharmaceuticals and Drugs. Aurinia has also won awards as the sole provider under Blanket Purchase Agreements with the Department of Veterans Affairs National Acquisition Center. A 2021 BPA with a potential value of $10 million aimed to procure Aurinia's recently FDA-approved lupus nephritis drug Lupkynis for veterans nationwide through July 2021. Another 2022 BPA allows VA medical facilities to purchase up to $7 million in Lupkynis from Aurinia through August 2024.
Additionally, Aurinia holds multiple Federal Supply Schedule contracts to supply pharmaceuticals via the GSA Schedules program. A 2021 contract with VISN 12 of the VA Health Administration covers drugs, pharmaceuticals and hematology products. Aurinia also has a Pharmaceuticals and Drugs schedule contract that has been leveraged as a purchasing vehicle by federal customers like the Bureau of Prisons and VA. Task orders under Aurinia's schedule contract vehicles have centered around procuring specialized medications to treat conditions prevalent among high-risk populations like veterans and inmates.
Quick answers
Is Aurinia Pharma US Inc. registered in SAM.gov?
Yes. Aurinia Pharma US Inc.'s SAM.gov registration is active through March 23, 2027.
Which contract vehicles does Aurinia Pharma US Inc. hold?
Aurinia Pharma US Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Aurinia Pharma US Inc.'s most recent federal award?
Aurinia Pharma US Inc.'s most recent federal contract award is Voclosprin for inmate claybon 59340-509 (15B31823F00000006), from Federal Correctional Institution Aliceville (BOP), on November 10, 2022.
On GovTribe
See Aurinia Pharma US Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors